These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
558 related items for PubMed ID: 27288457
1. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development. Lopez-Anido C, Poitelon Y, Gopinath C, Moran JJ, Ma KH, Law WD, Antonellis A, Feltri ML, Svaren J. Hum Mol Genet; 2016 Jul 15; 25(14):3055-3069. PubMed ID: 27288457 [Abstract] [Full Text] [Related]
2. Regulation of myelin-specific gene expression. Relevance to CMT1. Kamholz J, Awatramani R, Menichella D, Jiang H, Xu W, Shy M. Ann N Y Acad Sci; 1999 Sep 14; 883():91-108. PubMed ID: 10586235 [Abstract] [Full Text] [Related]
3. Regulation of the PMP22 gene through an intronic enhancer. Jones EA, Lopez-Anido C, Srinivasan R, Krueger C, Chang LW, Nagarajan R, Svaren J. J Neurosci; 2011 Mar 16; 31(11):4242-50. PubMed ID: 21411665 [Abstract] [Full Text] [Related]
4. Regulation of the neuropathy-associated Pmp22 gene by a distal super-enhancer. Pantera H, Moran JJ, Hung HA, Pak E, Dutra A, Svaren J. Hum Mol Genet; 2018 Aug 15; 27(16):2830-2839. PubMed ID: 29771329 [Abstract] [Full Text] [Related]
5. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury. Hung HA, Sun G, Keles S, Svaren J. J Biol Chem; 2015 Mar 13; 290(11):6937-50. PubMed ID: 25614629 [Abstract] [Full Text] [Related]
6. Pmp22 super-enhancer deletion causes tomacula formation and conduction block in peripheral nerves. Pantera H, Hu B, Moiseev D, Dunham C, Rashid J, Moran JJ, Krentz K, Rubinstein CD, Won S, Li J, Svaren J. Hum Mol Genet; 2020 Jun 27; 29(10):1689-1699. PubMed ID: 32356557 [Abstract] [Full Text] [Related]
7. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Perea J, Robertson A, Tolmachova T, Muddle J, King RH, Ponsford S, Thomas PK, Huxley C. Hum Mol Genet; 2001 May 01; 10(10):1007-18. PubMed ID: 11331611 [Abstract] [Full Text] [Related]
8. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies. Hanemann CO, Stoll G, D'Urso D, Fricke W, Martin JJ, Van Broeckhoven C, Mancardi GL, Bartke I, Müller HW. J Neurosci Res; 1994 Apr 01; 37(5):654-9. PubMed ID: 8028042 [Abstract] [Full Text] [Related]
9. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs. Hanemann CO, Gabreëls-Festen AA, Stoll G, Müller HW. Acta Neuropathol; 1997 Oct 01; 94(4):310-5. PubMed ID: 9341930 [Abstract] [Full Text] [Related]
10. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice. Lee JS, Lee JY, Song DW, Bae HS, Doo HM, Yu HS, Lee KJ, Kim HK, Hwang H, Kwak G, Kim D, Kim S, Hong YB, Lee JM, Choi BO. Nucleic Acids Res; 2020 Jan 10; 48(1):130-140. PubMed ID: 31713617 [Abstract] [Full Text] [Related]
12. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies. Müller HW. Ann N Y Acad Sci; 1999 Sep 14; 883():152-9. PubMed ID: 10586241 [Abstract] [Full Text] [Related]
13. SOX10 regulates an alternative promoter at the Charcot-Marie-Tooth disease locus MTMR2. Fogarty EA, Brewer MH, Rodriguez-Molina JF, Law WD, Ma KH, Steinberg NM, Svaren J, Antonellis A. Hum Mol Genet; 2016 Sep 15; 25(18):3925-3936. PubMed ID: 27466180 [Abstract] [Full Text] [Related]
14. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Sancho S, Young P, Suter U. Brain; 2001 Nov 15; 124(Pt 11):2177-87. PubMed ID: 11673320 [Abstract] [Full Text] [Related]
15. Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons. Maier M, Castagner F, Berger P, Suter U. Mol Cell Neurosci; 2003 Nov 15; 24(3):803-17. PubMed ID: 14664827 [Abstract] [Full Text] [Related]
16. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy. Matsuda N, Ootsuki K, Kobayashi S, Nemoto A, Kubo H, Usami SI, Kanani K. BMC Neurol; 2021 Jun 25; 21(1):243. PubMed ID: 34171997 [Abstract] [Full Text] [Related]
17. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Niemann A, Berger P, Suter U. Neuromolecular Med; 2006 Jun 25; 8(1-2):217-42. PubMed ID: 16775378 [Abstract] [Full Text] [Related]
18. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. Nobbio L, Vigo T, Abbruzzese M, Levi G, Brancolini C, Mantero S, Grandis M, Benedetti L, Mancardi G, Schenone A. Neurobiol Dis; 2004 Jun 25; 16(1):263-73. PubMed ID: 15207283 [Abstract] [Full Text] [Related]
19. PMP22 expression in dermal nerve myelin from patients with CMT1A. Katona I, Wu X, Feely SM, Sottile S, Siskind CE, Miller LJ, Shy ME, Li J. Brain; 2009 Jul 25; 132(Pt 7):1734-40. PubMed ID: 19447823 [Abstract] [Full Text] [Related]
20. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, Guedj M, Hajj R, Nabirotchkin S, Cohen D. Orphanet J Rare Dis; 2014 Dec 10; 9():201. PubMed ID: 25491744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]